Loading clinical trials...
Loading clinical trials...
The purpose of Part 1 is to inform dose selection for use of alisporivir and EDP239 in combination and obtain initial safety data for co-administration of alisporivir and EDP239 to support future trea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Enanta Pharmaceuticals, Inc
NCT06745895 · Colorectal Cancer Screening, Hepatitis C Virus
NCT06718530 · Hepatitis C Virus Infection
NCT06463912 · Hepatitis C Virus Infection
NCT05361603 · Hepatitis C, Transmission, Intravenous Drug Abuser, and more
NCT06868264 · HEPATITIS C VIRUS CHRONIC INFECTION
Investigative Site
Berlin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions